302 related articles for article (PubMed ID: 2095383)
1. Various approaches to blockade of the renin-angiotensin system: persistent renin response.
Brunner HR; Nussberger J; Waeber B
J Hypertens Suppl; 1990 Dec; 8(7):S149-53. PubMed ID: 2095383
[TBL] [Abstract][Full Text] [Related]
2. Inhibitors of the renin-angiotensin system.
Brunner HR; Nussberger J; Waeber B
Arzneimittelforschung; 1993 Feb; 43(2A):274-8. PubMed ID: 8498978
[TBL] [Abstract][Full Text] [Related]
3. Peptides as targets for antihypertensive drug development.
Hedner T; Sun X; Junggren IL; Pettersson A; Edvinsson L
J Hypertens Suppl; 1992 Dec; 10(7):S121-32. PubMed ID: 1291647
[TBL] [Abstract][Full Text] [Related]
4. Angiotensin II blockade compared with other pharmacological methods of inhibiting the renin-angiotensin system.
Brunner HR; Nussberger J; Waeber B
J Hypertens Suppl; 1993 Apr; 11(3):S53-8. PubMed ID: 8315521
[TBL] [Abstract][Full Text] [Related]
5. New therapeutic prospects of renin-angiotensin system inhibition.
Corvol P
Clin Exp Hypertens A; 1989; 11 Suppl 2():463-70. PubMed ID: 2691125
[TBL] [Abstract][Full Text] [Related]
6. [Comparison of angiotensin receptor antagonists and angiotensin converting enzyme inhibitors in arterial hypertension].
Krezsinski JM; Sternon J
Rev Med Brux; 2000 Jun; 21(3):170-7. PubMed ID: 10925600
[TBL] [Abstract][Full Text] [Related]
7. Novel therapies blocking the renin-angiotensin-aldosterone system in the management of hypertension and related disorders.
Krum H; Gilbert RE
J Hypertens; 2007 Jan; 25(1):25-35. PubMed ID: 17143168
[TBL] [Abstract][Full Text] [Related]
8. Effects of renin-angiotensin system inhibition on end-organ protection: can we do better?
Weir MR
Clin Ther; 2007 Sep; 29(9):1803-24. PubMed ID: 18035185
[TBL] [Abstract][Full Text] [Related]
9. [Oral inhibitors of renin and their potential use as therapeutic agents in treating hypertension].
Abassi Z; Armaly Z; Nakhoul F; Hoffman A
Harefuah; 2008 Jun; 147(6):536-42, 573. PubMed ID: 18693632
[TBL] [Abstract][Full Text] [Related]
10. [Comparison between the effects of angiotensin-converting enzyme inhibitors and angiotensin II antagonists].
Asmar R; Madonna O; Brisac AM; Benetos A; Laurent S
Therapie; 1998; 53(3):253-70. PubMed ID: 9773125
[TBL] [Abstract][Full Text] [Related]
11. Experience with angiotensin II antagonists in hypertensive patients.
Waeber B; Burnier M; Nussberger J; Brunner HR
Clin Exp Pharmacol Physiol; 1996 Sep; 23 Suppl 3():S142-6. PubMed ID: 21143288
[TBL] [Abstract][Full Text] [Related]
12. Clinical potential: angiotensin converting enzyme inhibitor or angiotensin II antagonist?
McInnes GT
J Hypertens Suppl; 2001 Jun; 19(1):S61-7. PubMed ID: 11451217
[TBL] [Abstract][Full Text] [Related]
13. Blockade of the renin-angiotensin system at different sites: effect on renin, angiotensin and aldosterone.
Abdelrahman AM; Burrell LM; Johnston CI
J Hypertens Suppl; 1993 Apr; 11(3):S23-6. PubMed ID: 8315514
[TBL] [Abstract][Full Text] [Related]
14. [Angiotensin II AT1 receptor antagonists: clinical development and future perspectives].
Burnier M; Brunner HR
Therapie; 1998; 53(3):279-84. PubMed ID: 9773127
[TBL] [Abstract][Full Text] [Related]
15. Inhibiting the renin-angiotensin system to prevent cardiovascular diseases: do we need a more comprehensive strategy?
Weber MA; Giles TD
Rev Cardiovasc Med; 2006; 7(2):45-54. PubMed ID: 16915123
[TBL] [Abstract][Full Text] [Related]
16. [Historical perspective of renin-angiotensin system blocking in the treatment of arterial hypertension].
Coca A; Redón J
Med Clin (Barc); 1996 Mar; 106(12):457-9. PubMed ID: 8656731
[No Abstract] [Full Text] [Related]
17. [Angiotensin II antagonists versus ACE inhibitors in the treatment of raised blood pressure].
Andersen RS; Christensen S
Ugeskr Laeger; 2001 Dec; 163(50):7036-9. PubMed ID: 11794033
[TBL] [Abstract][Full Text] [Related]
18. Hemodynamic effects of inhibitors of the renin-angiotensin system.
Fouad-Tarazi FM
J Hypertens Suppl; 1994 Jul; 12(2):S25-9. PubMed ID: 7965262
[TBL] [Abstract][Full Text] [Related]
19. Angiotensin II type 1 receptor blockade: a new development in cardiovascular pharmacology.
Leary AC; MacDonald TM
Int J Clin Pract; 1998 Oct; 52(7):475-81. PubMed ID: 10622089
[TBL] [Abstract][Full Text] [Related]
20. [Non-peptide antagonists to angiotensin II receptors. A review].
Schambye HT; Hjorth SA; Schwartz TW
Ugeskr Laeger; 1993 Nov; 155(44):3558-62. PubMed ID: 8236577
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]